Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells

Experimental Eye Research

Volumn 88, Issue 5, 2009, Pages 889-899

  Fuchshofer, Rudolf ^a   Yu, Alice L ^b   Teng, Hiang Hwa ^b   Strauss, Rupert ^b   Kampik, Anselm ^b   Welge Lussen, Ulrich ^b,c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

age related macular degeneration; extracellular matrix; hypoxia; reoxygenation; retinal pigment epithelium

Indexed keywords

COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; CELL HYPOXIA; CELLS, CULTURED; COLLAGEN TYPE IV; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACULAR DEGENERATION; MIDDLE AGED; OXYGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RETINAL PIGMENT EPITHELIUM; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; YOUNG ADULT;

EID: 64849096470     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.11.036     Document Type: Article

References (65)

1. Andreasen P.A., Egelund R., and Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57 (2000) 25-40
2. Arden G.B. Age-related macular degeneration. J. Br. Menopause Soc. 12 (2006) 64-70
3. Arden G.B., and Wolf J.E. Differential effects of light and alcohol on the electro-oculographic responses of patients with age-related macular disease. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3226-3232
4. Beatty S., Koh H., Phil M., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol 45 (2000) 115-134
5. Bird A.C. Bruch's membrane change with age. Br. J. Ophthalmol 76 (1992) 166-168
6. Blalock T.D., Duncan M.R., Varela J.C., Goldstein M.H., Tuli S.S., Grotendorst G.R., and Schultz G.S. Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1879-1887
7. Blokhina O., Virolainen E., and Fagerstedt K.V. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann. Bot. (Lond.) 91 Spec No (2003) 179-194
8. Brigstock D.R. The CCN family: a new stimulus package. J. Endocrinol 178 (2003) 169-175
9. Campochiaro P.A., Mimuro J., Sugg R., and Loskutoff D.J. Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cells. Exp. Eye Res. 49 (1989) 195-203
10. Ceriello A., Curcio F., dello Russo P., Pegoraro I., Stel G., Amstad P., and Cerutti P. The defence against free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-production. Blood Coagul. Fibrinolysis 6 (1995) 133-137
11. Chen C.P., Yang Y.C., Su T.H., Chen C.Y., and Aplin J.D. Hypoxia and transforming growth factor-beta 1 act independently to increase extracellular matrix production by placental fibroblasts. J. Clin. Endocrinol. Metab 90 (2005) 1083-1090
12. Distler J.H., Jungel A., Pileckyte M., Zwerina J., Michel B.A., Gay R.E., Kowal-Bielecka O., Matucci-Cerinic M., Schett G., Marti H.H., Gay S., and Distler O. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum 56 (2007) 4203-4215
13. Eitzman D.T., McCoy R.D., Zheng X., Fay W.P., Shen T., Ginsburg D., and Simon R.H. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest 97 (1996) 232-237
14. Erichsen J.T., Jarvis-Evans J., Khaliq A., and Boulton M. Oxygen modulates the release of urokinase and plasminogen activator inhibitor-1 by retinal pigment epithelial cells. Int. J. Biochem. Cell Biol. 33 (2001) 237-247
15. Fink T., Kazlauskas A., Poellinger L., Ebbesen P., and Zachar V. Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 99 (2002) 2077-2083
16. Fogo A.B. Mesangial matrix modulation and glomerulosclerosis. Exp. Nephrol 7 (1999) 147-159
17. Fogo A.B. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am. J. Kidney Dis 35 (2000) 179-188
18. Glazer-Hockstein C., and Dunaief J.L. Could blue light-blocking lenses decrease the risk of age-related macular degeneration?. Retina 26 (2006) 1-4
19. Grotendorst G.R., Okochi H., and Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7 (1996) 469-480
20. Grunwald J.E., Metelitsina T.I., Dupont J.C., Ying G.S., and Maguire M.G. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1033-1038
21. Guymer R.H., and Chong E.W. Modifiable risk factors for age-related macular degeneration. Med. J. Aust 184 (2006) 455-458
22. Haddad S., Chen C.A., Santangelo S.L., and Seddon J.M. The genetics of age-related macular degeneration: a review of progress to date. Surv. Ophthalmol 51 (2006) 316
23. He S., Jin M.L., Worpel V., and Hinton D.R. A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization. Arch. Ophthalmol 121 (2003) 1283-1288
24. Higgins D.F., Biju M.P., Akai Y., Wutz A., Johnson R.S., and Haase V.H. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am. J. Physiol. Renal Physiol 287 (2004) F1223-F1232
25. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr. Opin. Rheumatol 14 (2002) 681-685
26. Ito Y., Aten J., Bende R.J., Oemar B.S., Rabelink T.J., Weening J.J., and Goldschmeding R. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53 (1998) 853-861
27. Jiang Z., Seo J.Y., Ha H., Lee E.A., Kim Y.S., Han D.C., Uh S.T., Park C.S., and Lee H.B. Reactive oxygen species mediate TGF-beta1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells. Biochem. Biophys. Res. Commun 309 (2003) 961-966
28. Kietzmann T., Roth U., and Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94 (1999) 4177-4185
29. Kigasawa K., Ishikawa H., Obazawa H., Minamoto T., Nagai Y., and Tanaka Y. Collagen production by cultured human retinal pigment epithelial cells. Tokai J. Exp. Clin. Med 23 (1998) 147-151
30. Kim K.H., Park G.T., Lim Y.B., Rue S.W., Jung J.C., Sonn J.K., Bae Y.S., Park J.W., and Lee Y.S. Expression of connective tissue growth factor, a biomarker in senescence of human diploid fibroblasts, is up-regulated by a transforming growth factor-beta-mediated signaling pathway. Biochem. Biophys. Res. Commun 318 (2004) 819-825
31. Kondo S., Kubota S., Shimo T., Nishida T., Yosimichi G., Eguchi T., Sugahara T., and Takigawa M. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23 (2002) 769-776
32. Kondo S., Tanaka N., Kubota S., Mukudai Y., Yosimichi G., Sugahara T., and Takigawa M. Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells. Mol. Cancer Ther 5 (2006) 129-137
33. Leask A., Denton C.P., and Abraham D.J. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J. Invest. Dermatol 122 (2004) 1-6
34. Lee H.B., and Ha H. Plasminogen activator inhibitor-1 and diabetic nephropathy. Nephrology (Carlton) 10 Suppl (2005) S11-S13
35. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med 36 (2004) 1-12
36. Leschey K.H., Hackett S.F., Singer J.H., and Campochiaro P.A. Growth factor responsiveness of human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 31 (1990) 839-846
37. Leu S.T., Batni S., Radeke M.J., Johnson L.V., Anderson D.H., and Clegg D.O. Drusen are cold spots for proteolysis: expression of matrix metalloproteinases and their tissue inhibitor proteins in age-related macular degeneration. Exp. Eye Res. 74 (2002) 141-154
38. Levinson R.M., Shure D., and Moser K.M. Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am. Rev. Respir. Dis 134 (1986) 1241-1245
39. Li C., and Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol 282 (2002) C227-C241
40. Li C., Wright M.M., and Jackson R.M. Reactive species mediated injury of human lung epithelial cells after hypoxia-reoxygenation. Exp. Lung Res. 28 (2002) 373-389
41. Lijnen H.R. Pleiotropic functions of plasminogen activator inhibitor-1. J. Thromb. Haemost 3 (2005) 35-45
42. Liu Q., Moller U., Flugel D., and Kietzmann T. Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1. Blood 104 13 (2004) 3993-4001
43. Marshall G.E., Konstas A.G., Reid G.G., Edwards J.G., and Lee W.R. Collagens in the aged human macula. Graefes Arch. Clin. Exp. Ophthalmol 232 (1994) 133-140
44. Marx J. Genetics. A clearer view of macular degeneration. Science 311 (2006) 1704-1705
45. McCarty C.A., Mukesh B.N., Fu C.L., Mitchell P., Wang J.J., and Taylor H.R. Risk factors for age-related maculopathy: the visual impairment project. Arch. Ophthalmol 119 (2001) 1455-1462
46. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med 312 (1985) 159-163
47. Mitchell P., Wang J.J., Smith W., and Leeder S.R. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol 120 (2002) 1357-1363
48. Mukai Y., Wang C.Y., Rikitake Y., and Liao J.K. Phosphatidylinositol 3 kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol 292 (2007) 1937-1942
49. Newsome D.A., Pfeffer B.A., Hewitt A.T., Robey P.G., and Hassell J.R. Detection of extracellular matrix molecules synthesized in vitro by monkey and human retinal pigment epithelium: influence of donor age and multiple passages. Exp. Eye Res. 46 (1988) 305-321
50. Paradis V., Dargere D., Vidaud M., De Gouville A.C., Huet S., Martinez V., Gauthier J.M., Ba N., Sobesky R., Ratziu V., and Bedossa P. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30 (1999) 968-976
51. Park S.K., Kim J., Seomun Y., Choi J., Kim D.H., Han I.O., Lee E.H., Chung S.K., and Joo C.K. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem. Biophys. Res. Commun 284 (2001) 966-971
52. Pinsky D.J., Liao H., Lawson C.A., Yan S.F., Chen J., Carmeliet P., Loskutoff D.J., and DM S. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J. Clin. Invest 102 (1998) 919-928
53. Priglinger S.G., May C.A., Neubauer A.S., Alge C.S., Schonfeld C.L., Kampik A., and Welge-Lussen U. Tissue transglutaminase as a modifying enzyme of the extracellular matrix in PVR membranes. Invest. Ophthalmol. Vis. Sci. 44 (2003) 355-364
54. Robin E.D., and Theodore J. Ischemic lung disease, including a new look at Va/Qc. Chest 82 (1982) 659-661
55. Seddon J.M., George S., and Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch. Ophthalmol 124 (2006) 995-1001
56. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med 7 (2001) 345-350
57. Tuan T.L., Zhu J.Y., Sun B., Nichter L.S., Nimni M.E., and Laug W.E. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J. Invest. Dermatol 106 (1996) 1007-1011
58. van der Schaft T.L., de Bruijn W.C., Mooy C.M., Ketelaars D.A., and de Jong P.T. Is basal laminar deposit unique for age-related macular degeneration?. Arch. Ophthalmol 109 (1991) 420-425
59. Watanabe D., Takagi H., Suzuma K., Oh H., Ohashi H., and Honda Y. Expression of connective tissue growth factor and its potential role in choroidal neovascularization. Retina 25 (2005) 911-918
60. Weidemann A., and Johnson R.S. Biology of HIF-1alpha. Cell Death Differ 15 (2008) 621-627
61. Welge-Lussen U., May C.A., and Lutjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2. Invest. Ophthalmol. Vis. Sci. 41 (2000) 2229-2238
62. Wileman S.M., Booth N.A., Moore N., Redmill B., Forrester J.V., and Knott R.M. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells. Br. J. Ophthalmol 84 (2000) 417-422
63. Yang C., Zeng S., and Lv M. Effect of shRNA inhibiting HiF1alpha gene on TIMP1 expression in RPE cells. J. Huazhong Univ. Sci. Technol. Med. Sci 26 (2006) 133-136
64. Zhang Q., Wu Y., Ann D.K., Messadi D.V., Tuan T.L., Kelly A.P., Bertolami C.N., and AD L. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J. Invest. Dermatol 121 (2003) 1005-1012
65. Zhou Z., Liu Y., Miao A.D., and Wang S.Q. Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells. J. Cell. Biochem 96 (2005) 109-116